4th Quarter - Report

TIBER CREEK HEALTH STRATEGIES, INC. for NOVARTIS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Tax issues related to orphan drugs. ACA Implementation. Issues related to 340b pricing.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: SENATE

Health Issues HCR

Issues related to S. 2041, Promoting Life-Saving New Therapies for Neonates Act of 2015. Issues related to biosimilars and biosimilars coding.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: SENATE

Bills named: S. 2041 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.